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Abstract
This case reports an immunocompetent 29-year-old woman with suspected pneumonia, suggestive of fungal
infection. Immunoblotting analysis reactivity against Histoplasma capsulatum and Paracoccidioides brasiliensis were
observed. Nested-PCR in blood employing species-specific primers was positive for H. capsulatum and Cryptococcus
neoformans. The evaluation of paucisymptomatic patients with positive results for H. capsulatum and C. neoformans
could be relevant for the prevention as well as the possible evaluation of the reactivated quiescent foci. In conclusion,
the associated methodology may have contributed to the monitoring endogenous reactivation of these diseases.
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Background
Fungal infection of the respiratory tract can take several
forms, the most common of which is pneumonia [1]. How-
ever, the number of etiologic agents attacking immunocom-
petent individuals and causing significant infection is
limited. The most common of these are Aspergillus spp.,
Pneumocystis jirovecii, Cryptococcus spp., Histoplasma
capsulatum, Scedosporium spp., Fusarium spp. and Can-
dida spp. [1].
Histoplasmosis (HP) is a systemic disease caused by the
thermally dimorphic fungus Histoplasma capsulatum. HP
is a cosmopolitan mycosis with areas of particularly high
endemicity [2]. In Brazil, endemic areas are located in the
midwestern and southeastern regions of the country [3].
Humans infected by H. capsulatum experience an
unapparent or mild disease and usually develop a positive
reaction to a histoplasmin skin test within two weeks after
exposure [2,4]. The clinical spectrum ranges from asymp-
tomatic, self-limited illness to a life-threatening progres-
sive disseminated disease [2].
Cryptococcus spp. are widespread fungi in many parts of
the world, and are responsible for cryptococcosis, the most
common opportunistic infection in patients with AIDS
[5,6]. The acute form of the disease is more common in
immunodeficient patients, such as those infected with HIV,
those treated with corticosteroids, and those with other
types of immunodeficiency (related to tuberculosis,
diabetes mellitus, hematologic cancers, or chemotherapy).
A chronic form characterized by discrete mild symptoms
or no symptoms is observed in immunocompetent indivi-
duals [6]. In Brazil, the major cases of cryptococcosis in
regions south, southwest and central-east occurred in
patients with AIDS. In addition, findings from the northern
and northeastern regions show that this infection may also
be associated with outbreaks [5].
Concomitant cryptococcosis and histoplasmosis are
rarely reported in the literature. Aronis et al. [7] reported
concomitant disseminated histoplasmosis and crypto-
coccosis in a 20-years-old Brazilian woman with AIDS.
Furthermore, the authors reported cases described in the
medical literature showing, from January 1970 to December
2010, only five cases of coinfection by H. capsulatum and
C. neoformans in patients in Europe and South and North
America [7].
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The infection occurs after inhalation of the fungal
propagules by the host [4]. Infections often follow
human disruption of the soil during spelunking, farming,
cleaning attics, bridges or barns, construction and tear-
ing down old structures laden with bat and/or bird
guano; all of these activities tend to aerosolize the fungal
propagules. The risk of infection as well as the spectrum
of clinical manifestations depend mainly on the magnitude
of exposure, professional occupation and activity duration.
The manifestations of mycoses were influenced by genetic
and environmental conditions such as the amount of the
fungal propagules in the soil, the immune status of the
host and the virulence of the infecting strain [8]. Epidemi-
ology of fungal infections is important in immunocompe-
tent individuals, especially when the available diagnostic
tools do not show conclusive results [9,10].
Definitive diagnosis is still based on the isolation and
identification of the etiological agent, by growth of the
fungi from sputum, blood, tissue biopsy or biological spec-
imens [8,9,11]. If neither cultural nor morphological proof
of infection is available, other approaches must be used
[8,9,11]. In contrast to other endemic mycoses, serologic
assays for detection of specific host antibody responses
and/or antigen detection often provide this additional
information for the diagnosis of histoplasmosis and
cryptococcosis [4,6,9,12].
Because of their convenience, availability, utility and
accuracy, the most widely accepted immunological assays
are immunodiffusion, complement fixation and latex
aggluttination [5]. However, these methods have limita-
tions associated with false positivity, mainly in patients
with the disseminated form of disease. False positive
results occur most frequently in the presence of cross-
reactive epitopes shared with other fungal pathogens like
Paracoccidioides brasiliensis, Coccidioides immitis and
Aspergillus sp [8,9,13]. In addition, Yeo and Wong [13], in
a review article, showed that DNA-based diagnostic tests
have the potential to reduce the time for laboratory identifi-
cation of pathogens that are slow growing or difficult to
culture. Guedes et al. [12] employed the PCR method for
the detection and identification of H. capsulatum. The PCR
assay was developed with specific primer pairs whose
sequences were based on the H. capsulatum M-protein gene
sequence, a test proven sensitive and specific for the identifi-
cation of typical and atypical isolates of this fungal species.
The primer pairs were specific for Cryptococcus spp. whose
sequence was based on the 18S rDNA region [14].
We report herein a case of histoplasmosis and crypto-
cocosis infection in a young HIV-negative woman. She
had visited the countryside of Bahia, in northeastern
Brazil. Our goal was to demonstrate the importance of the
association of molecular and immunological diagnoses in
a blood sample from an immunocompetent patient with
suspected fungal infection.
Case presentation
A immunocompetent 29-years-old woman patient, who
lives in São Paulo, was referred to the Emilio Ribas Insti-
tute in January 2008 with suspected pneumonia. At that
time, the patient was not taking any medication and had
no history of systemic disease. She did not report previous
blood transfusions or surgeries. The patient reported a
history of traveling to a rural area in Bahia state, Brazil.
Importantly, she related that she had direct contact with
chicken excreta while cleaning a coop and had taken in-
adequate precautions.
Approximately 20 days after returning to São Paulo, the
patient presented intermittent fever, productive cough,
chest pain, dyspnea, and myalgia for three months. A gen-
eral clinical examination revealed a patient with normal
skin color, afebrile, hydrated, non-cyanotic and non-
edematous; no lymphadenopathy or hepatosplenomegaly
was observed. The abdomen was soft and non-rigid with
normal bowel sounds. Cardiac auscultation revealed a
regular rate and rhythm, and normal breath sounds. Anti-
bodies against HIV, viral hepatitis, leishmaniasis, Chagas’
disease, malaria, paracoccidioidomycosis, histoplasmosis
and aspergillosis, as well as skin tests for paracoccidioidin
and histoplasmin were negative. Serum cryptococcal anti-
gen latex agglutination test was negative. Direct sputum
examination was negative in three samples for fungus and
acid-alcohol resistant bacillus. The isolation from serial
blood samples collected and inoculated under sterile con-
ditions on Sabouraud-dextrose brain-heart infusion (Difco
Laboratories, USA), and tryptone soya broth (Oxoid, UK),
incubated at 30°C and at 35°C were all negative. Radio-
logical images proved to be inconclusive, with no patho-
logical changes.
During the clinical evaluation, the patient had sponta-
neous resolution of the clinical picture; therefore, it was
not necessary to request additional tests such as CT or
echocardiogram. The epidemiological history was compa-
tible between histoplasmosis and cryptococcosis. Double
immunodiffusion and immunoblotting assays were per-
formed according to Freitas et al. [9], whereas the serum
cryptococcal antigen latex agglutination test was per-
formed using the IMMY kit (Immuno-Mycologics, USA),
according to the manufacturer’s instructions. Double
immunodiffusion (DI) produced no detectable reactivity of
the serum samples against H. capsulatum and P. brasilien-
sis antigens. By immunoblotting there was reactivity with
the H and M fractions of H. capsulatum as well as gp43 of
P. brasiliensis. DNA was extracted by means of a kit
(QIAamp Kit Blood Mini genomico; QIAgen, USA). The
reaction conditions and the primers were chosen accor-
ding to previous studies [14-18]. Negative (water) controls
were tested simultaneously.
All reactions were accompanied by either a negative
control (no added DNA), or a positive control (strains
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references for H. capsulatum – 200, C. neoformans –
ATCC 24067, and P. brasiliensis – 18 and B-339) and
negative group control (seven healthy individuals). Blood
and serum samples from the patient were evaluated mo-
lecularly over 12 months. During this period, we detected
DNA for C. neoformans for eight months, versus six
months for that of H. capsulatum. Nested PCR reactions
were processed and analyzed three times. The presence of
amplified DNA was confirmed by a nested PCR using a
target sequence of GenBank accession number J04038.1 of
the human glyceraldehydes-3-phosphate dehydrogenase
(GADPH) as elsewhere described [19]. The nested-PCR in
blood and serum samples, using species-specific primers
HC18S, HC100, PBGP43 and CN18S were positive for H.
capsulatum and C. neoformans, but negative for P. brasi-
liensis, showing the possible infection by H. capsulatum
observed in immunoblotting [14-18].
The PCR product of the conserved region 5.8S rDNA-
ITS was obtained under the conditions described by
Fujita et al. [20]. Purification of this product was
performed with the PureLink kit (Invitrogen, Life Tech-
nologies, USA). From this purified product, sequencing
was performed using MegaBACE 1000, a system for
simultaneous DNA analysis with 96 capillaries from GE
Healthcare, CA, USA). The sequencing reactions were
performed according to the protocol for the Mega BACE
1000, using DYEnamic ET Dye Terminator kit (with
Thermo Sequence II DNA Polymerase, GE Healthcare,
USA). All sequences were analyzed by means of the
software Sequence Analyzer, using the Base Caller
Cimarron 3.12. The sequences were identified using the
BLAST program (http://www.ncbi.nlm.nih.gov/BLAST).
Furthermore, multiple alignments were assembled using
ClustalW (http://www.ebi.ac.uk). The sequences resulting
from this study were made available for public databases.
The results of sequencing showed that all strains were
C. neoformans and exhibited 98% similarity with the
neoformans variety. The sequencing of strains con-
firmed the results of tests that involved Nested PCR.
Discussion
In this study, we show the relevance of laboratory diagno-
sis in the clinical setting of an immunocompetent patient.
According to the literature, the clinical manifestation by
fungal infection can range from asymptomatic infection to
dissemination [4,21-23]. The patient of this study showed
the initial clinical suspicion of pneumonia. However, the
results of radiological images, according to Wheat and
Kauffman [2], are commonly negative in immunocompe-
tent patients. In relation to the treatment, the patient did
not require therapy with spontaneous resolution, confir-
ming the description by Wheat et al. [24] and Bicanic and
Harrison [25] in immunocompetent patients.
Although this case was reported in São Paulo, we have
strong evidence that the patient had become infected in
the Brazilian state of Bahia. Thus, we believe in the exis-
tence of microfoci for both H. capsulatum and for C.
neoformans, as found in a rural chicken coop or in soil.
Despite the description of cases in northeastern Brazil, this
region is not considered endemic [26-29]. According to
Guimarães et al. [3] the northeast presents a histoplasmosis
prevalence of 2-29%. In Ceará, the incidence of histoplas-
mosis has more than doubled among patients with AIDS in
the past decade [26,30,31]. Fortaleza et al. [10] reported
one case of an immunocompetent patient with histoplas-
mosis that developed a severe form of the disease, presum-
ably due to the intensity of exposure and delayed diagnosis.
Cryptococcosis and histoplasmosis are the most common
fungal life-threatening infections in AIDS patients. However,
coinfection with these pathogens is rarely described in the
literature [7]. In this study, we show a case of an immuno-
competent patient with strong evidence of coinfection by
H. capsulatum and C. neoformans. However, due to the as-
sociation of serological and more sensitive molecular
methods, their detection was possible from the early phase
of fungal infection. The mycological diagnoses from serial
blood samples were negative, according to Wheat [32], in
immunocompetent individuals. This demonstrated that the
culture has low sensitivity to isolated fungi [4,11,32].
Serological evaluation is central to the diagnosis of some
acute, recent or chronic infectious diseases. In histoplas-
mosis infections, the detection of patients’ antibody re-
sponses offers a more rapid alternative to microbiological
means of diagnosis, and the detection of host anti-H.
capsulatum antibodies by immunodiffusion (ID). The
scarcity of the fungus in clinical specimens and a negative
serology result due to anergy or the low sensitivity of the
assays are common problems [9].
Katzenstein [33] studied specificity of skin tests in deep
fungal infection, showing that the response to skin testing
is closely related to the concentration of antigen employed.
In this paper, the author confirms the anergic state, since
the reaction of delayed-type hypersensitivity showed no re-
sponse. Infection by H. capsulatum was later confirmed at
autopsy [33]. The reaction of nested PCR was positive for
H. capsulatum and C. neoformans, and negative for P. bra-
siliensis, showing the possible infection by H. capsulatum
observed in immunoblotting (Figure 1A).
The recognition of the 43 kDa glycoprotein of P. brasi-
liensis in immunoblotting may be due to cross reactivity
with similar epitope of these two pathogens [9]. In this
report, we used nested PCR for the diagnosis of fungal
infection and confirmed that this assay is specific for H.
capsulatum and C. neoformans and could detect 1 cell/
mL. Therefore, this technique was considered another
useful method for the diagnosis of histoplasmosis and
cryptococcosis. The primer sequences used in this study
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were based on the small-subunit (18S) rDNA gene and
specific 100 kDa protein of H. capsulatum [34]. They did
not show any false-positive results and were able to detect
fungal DNA in serum and blood samples [14,16,18]. The
positive result for Cryptococcus spp., in which fungal DNA
was detected in serum and blood samples suggested a
concomitant infection, principally by epidemiological
similarity (Figure 1B).
The result of these studies is that PCR can be a useful
additional tool for diagnosis of H. capsulatum and C.
neorformans, especially in non-endemic regions, to
complement antibody detection and serological methods.
The monitoring of asymptomatic patients with confirmed
infection by H. capsulatum and C. neoformans may also
have relevance in the prevention and monitoring of possible
reactivation of quiescent foci, common in systemic myco-
ses, and thus contribute to the pathogenesis and epidemio-
logical knowledge of these diseases.
The nested PCR tested negative for detection of DNA
fragment specific for P. brasiliensis, which seems to corro-
borate the hypothesis of cross-reactivity, as this technique
is more specific than immunoblotting. The patient's serum
presented the fragment of the 18S region, conserved for
fungi, as well as the specific primer region of the gene that
encodes a protein of 100 kDa (fraction M of H. capsula-
tum). Figure 1 displays the PCR results from the nucleic
acids extracted from the blood and serum. GAPDH nested
PCR products obtained from this patient positively
confirmed that the samples were from human material.
In view of the seriousness of fungal infection, and the
scarcity of data on improvement of procedures in the
detection and identification of fungi, this study seems to
present clinically relevant and actionable results. We
believe that testing of biological fluids (blood and serum)
with primer sequences targeting rDNA and ITS regions
for the detection of H. capsulatum and C. neoformans will
improve diagnostic procedures and monitoring of these
infections. It is necessary to point out that in clinical prac-
tice, collection of biological samples after the onset of
severe symptoms and failure to detect small concentra-
tions of a fungal antigen prevent early laboratory diagnosis
of histoplasmosis and cryptococcosis, timely initiation of
therapy, and accurate prognosis of the disease. We expect
that a molecular diagnostic test diagnosis is a fast and
reliable means of improving the management of crypto-
coccosis and histoplasmosis.
Conclusion
The present case reinforces the idea that other more sensi-
tive and specific diagnostic methods, such as the immuno-
sorbent and molecular biology methods, are necessary to
confirm a diagnosis, especially when these patients have
generated a strong clinical suspicion. Therefore, in the pres-
ence of negative serologic reactions, the molecular biology
diagnostic tools are important for confirming the fungal
infection, thereby allowing diagnosis and successful therapy
and prognosis.
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Figure 1 Immunoblotting and PCR assays. (A): Immunoreactivity of serum patient against H and M fractions of H. capsulatum. (B): Lane M.
DNA molecular weight marker 1kb DNA ladder; Lane 1. patient serum collected in February 2008; Lane 2.- patient serum collected in June 2008;
Lanes 3 to 10. negative individual sera samples, Lane Hc1. H. capsulatum strain (immunodeficiency); Lane Hc2. H. capsulatum 200 strain; Lane Pb
18. P. brasiliensis strain; Lane Pb 339 P. brasiliensis 339, Lane CN1 e CN2. C. neoformans strains (ATCC 24067) and Lane NO. negative control.
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